Austrian researchers develop potential AIDS treatment breakthrough

The research is based on a substance known as resveratrol, that occurs naturally in grapes

HIV/AIDS
<a href="http://www.shutterstock.com/pic-135725843/stock-photo-aids-awareness-red-ribbon-isolated-on-black-with-aids-word.html" target="_blank">HIV/AIDS</a> image via Shutterstock
IANS Vienna
Last Updated : Jul 12 2016 | 12:58 PM IST

Austrian researchers have developed a treatment that could spell a breakthrough in the treatment of AIDS, the Krone newspaper reported on Monday.

The research duo of Thomas Szekeres, a human geneticist who also serves as President of the Vienna Medical Association, and Walter Jaeger, a pharmacist, said the arduous research project spanned 15 years.

Jaeger said while it was "full of setbacks", there were also often "new hopes", and they are now satisfied with the research results and ready to make them public, Xinhua reported.

The research is based on a substance known as resveratrol, that occurs naturally in grapes as a means of defence against fungi and bacteria.

Based on this substance as well as a similar artificially developed chemical compound known as "M8", Szekeres conducted research into a substance, that Jaeger then developed, that is to inhibit the growth of HIV.

"We have meticulously proven this in human cells. And if is effective there, it can also begin healing processes in human HIV sufferers," Szekeres said according to the report.

The researchers were assisted in the project by several Canadian institutes such as the McGill University AIDS Centre and the Lady Davis Institute for Medical Research affiliated with the Jewish General Hospital.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 12 2016 | 1:14 AM IST

Next Story